Asia · Regional markets · Korea Economic Daily

Samsung Biologics wins nearly full backing in PolyPeptide tender offer

Published by Korea Economic Daily · South Korea 17 h ago

Samsung Biologics Co. said on Monday its tender offer for PolyPeptide Group drew 97.98% final acceptances, clearing both the minimum threshold for the 1.46 bil ...

Read the full article on Korea Economic Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.kedglobal.com)

Also worth reading

Tech in Asia

Oyo parent Prism posts $37m profit, revenue up 35%

CNBC-TV18

Sensex Today | Stock Market LIVE Updates: GIFT Nifty up 110 pts; ITC in focus after results

Mint

Top stocks to watch today: SBI, NSE, ITC, Sun Pharma, IDBI Bank shares in focus on Tuesday, 3 Nov | Full list

The Straits Times Business

Oil rises after report of US strike on Iran’s Qeshm Island

The Business Times

STI’s total returns slide 5.2% in October; tech index plunges 17.3%

Business Standard